OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

NCT02140580 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

486

Enrollment

OTHER

Sponsor class

Conditions

Bronchopulmonary Dysplasia

Interventions

DEVICE: Minimally invasive surfactant therapy
OTHER: Continuation on CPAP

Sponsor

Menzies Institute for Medical Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]